RajivKumarMD

PubMed

• 3 citations
  Cholesterol Homeostasis, Mechanisms of Molecular Pathways, and Cardiac Health: A Current Outlook.
  Rajiv Kumar, Neelam Chhillar, Dhruv Sanjay Gupta, Ginpreet Kaur, Shailey Singhal
  Current Problems in Cardiology. 2024-01-01
• Author Correction: Skeletal and extraskeletal disorders of biomineralization.
  Michael T Collins, Gemma Marcucci, Hans-Joachim Anders, Giovanni Beltrami, Jane A Cauley
  Nature Reviews. Endocrinology. 2023-01-01
• 25 citations
  Skeletal and extraskeletal disorders of biomineralization.
  Michael T Collins, Gemma Marcucci, Hans-Joachim Anders, Giovanni Beltrami, Jane A Cauley
  Nature Reviews. Endocrinology. 2022-08-01

Journal Articles

• Thrombopoietin promotes nhej dna repair in hematopoietic stem cells through specific activation of erk and nf-kappa b pathways and their target, iex-1  
  de Laval B, Pawlikowska P, Barbieri D, Besnard-Guerin C, Cico A, Kumar R , Gaudry M, Baud V, Porteu F, Blood, 1/23/2014
• Detection of 1 alpha,25-dihydroxyvitamin D-regulated miRNAs in zebrafish by whole transcriptome sequencing  
  Craig TA, Zhang Y, Magis AT, Funk CC, Price ND, Ekker SC, Kumar R, Zebrafish, 1/1/2014
• Characterization of the effect of chronic administration of a calcium-sensing receptor antagonist, ronacaleret, on renal calcium excretion and serum calcium in postmen...  
  Caltabiano S, Dollery CT, Hossain M, Kurtinecz MT, Desjardins JP, Favus MJ, Kumar R , Fitzpatrick LA, Bone, 1/1/2013
• Osteocalcin and the regulation of glucose metabolism  
  Vella A, Kumar R, Clinical Reviews in Bone and Mineral Metabolism, 1/1/2013
• Hypercalcemia, hypercalciuria, and elevated calcitriol concentrations with autosomal dominant transmission due to CYP24A1 mutations: effects of ketoconazole therapy  
  Tebben PJ, Milliner DS, Horst RL, Harris PC, Singh RJ, Wu Y, Foreman JW, Chelminski PR, Kumar R, J Clin Endocrinol Metab., 3/1/2012
• Hydrogen/deuterium exchange reflects binding of human centrin 2 to Ca 2+ and Xeroderma pigmentosum Group C peptide: An example of EX1 kinetics  
  Sperry JB, Ryan ZC, Kumar R, Gross ML, International Journal of Mass Spectrometry, 1/1/2012
• Serum 25-hydroxyvitamin D is associated with enhanced pneumococcal antibody levels in individuals with asthma  
  Lee J, Zhao H, Fenta Y, Kita H, Kumar R, Juhn YJ, Allergy Asthma Proc., 11/1/2011
• Tumor-Induced Osteomalacia  
  Kumar R , Folpe AL, Mullan BP, Translational Endocrinology & Metabolism, 1/1/2011
• KDOQI US commentary on the 2009 KDIGO Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of CKD-Mineral and Bone Disorder (CKD-MBD)  
  Uhlig K, Berns JS, Kestenbaum B, Kumar R , Leonard MB, Martin KJ, Sprague SM, Goldfarb S, Am J Kidney Dis., 5/1/2010
• ATM-dependent expression of IEX-1 controls nuclear accumulation of Mcl-1 and the DNA damage response  
  Pawlikowska P, Leray I, De Laval, Guihard S, Kumar R , Rosselli F, Porteu F, Cell Death Differ, 1/1/2010
• Mechanisms of renal phosphate loss in liver resection-associated hypophosphatemia  
  Nafidi O, Lapointe RW, Lepage R, Kumar R , D'Amour P, Ann Surg., 5/1/2009
• Increased expression of Wnt2 and SFRP4 in Tsk mouse skin: role of Wnt signaling in altered dermal fibrillin deposition and systemic sclerosis  
  Bayle J, Fitch J, Jacobsen K, Kumar R , Lafyatis R, Lemaire R, J Invest Dermatol, 4/1/2008
• Hyperoxaluric nephrolithiasis is a complication of Roux-en-Y gastric bypass surgery  
  Sinha MK, Collazo-Clavell ML, Rule A, Milliner DS, Nelson W, Sarr MG, Kumar R , Lieske JC, Kidney Int., 7/1/2007
• a LC-MS method for the quantification of urinary albumin using a novel 15N-isotopically-labeled albumin internal standard  
  R Singh, Babic N, Lutz W, Crow F, Lieske J, Larson T, Kumar R, Clin Chem., 1/1/2007
• Clinical relevance of the phosphatonins  
  Shaikh A, Kumar R, Neph-SAP, 1/1/2007
• Application of liquid chromatography-mass spectrometry technology for early detection of microalbuminuria in patients with kidney disease  
  Babic N, Larson TS, Grebe SK, Turner ST, Kumar R , Singh RJ, Clin Chem., 11/1/2006
• The phosphatonins and the regulation of phosphate homeostasis  
  Kumar R, Ann Endocrinol (Paris), 4/1/2006
• FGF-23 and sFRP-4 in chronic kidney disease and post-renal transplantation  
  Pande S, Ritter CS, Rothstein M, Wiesen K, Vassiliadis J, Kumar R , Schiavi SC, Slatapolsky E, Brown AJ, Nephron - Physiology, 1/1/2006
• The phosphatonins and the regulation of phosphorus homeostasis A perspective  
  Berndt T, Kumar R, BoneKEy-Osteovision, 1/1/2005
• The effects of Ca2+ binding on the conformation of calbindin D-28K: A nuclear magnetic resonance and microelectrospray mass spectrometry study  
  Venters RA, Benson LM, Craig TA, Paul KH, Kordys DR, Thompson R, Naylor S, Kumar R , Cavanagh J, Anal Biochem., 6/1/2003
• Emerging role of mass spectrometryin structural and functional apoptosis  
  S Naylor, Kumar R, Adv in Protein Chem., 1/1/2003
• Ontogeny of Phex/PHEX protein expression in mouse embryo and subcellular localization in osteoblasts  
  Thompson DL, Sabbagh Y, Tenenhouse HS, Roche PC, Drezner MK, Salisbury JL, Grande JP, Poeschla EM, Kumar R, J Bone Miner Res., 2/1/2002
• IEX-1, an immediate early gene, increases the rate of apoptosis in keratinocytes  
  Schilling D, Pittelkow MR, Kumar R, Oncogene, 11/29/2001
• FGF-23 inhibits renal tubular phosphate transport and is a PHEX substrate  
  Bowe AE, Finnegan R, Jan de Beur SM, Cho J, Levine MA, Kumar R , Schiavi SC, Biochem Biophys Res Commun., 6/22/2001
• Dendritic cell modulation by 1alpha,25 dihydroxyvitamin D3 and its analogs: a vitamin D receptor-dependent pathway that promotes a persistent state of immaturity in vi...  
  Griffin MD, Lutz W, Phan VA, Bachman LA, McKean DJ, Kumar R, Proc Natl Acad Sci U S A, 6/5/2001
• Join now to see all

Books/Book Chapters

• Seldin and Geibisch's The Kidney 
  Chapter: Clinical disturbances of phosphate homeostasis. 
  Page 2369 - 2391Berndt TJ, Kumar R2013
• Seldin and Geibisch's The Kidney 
  Chapter: The hormonal regulation of calcium metabolism. 
  Page 2249 - 2272Tebben PJ, Kumar R2013
• Osteoporosis 
  Chapter: Phosphatonins. 
  Page 373 - 390Tebben PJ, Berndt TJ, Kumar REdition Four,2013
• Decision Support in Medicine 
  Chapter: Hypophosphatemia. 
  Kumar R2013
• Fundamentals of Osteoporosis. 
  Chapter: Phosphatonins. 
  Page 413 - 428Tebben PJ, Berndt TJ, Kumar REditors: Marcus R; et al..Academic Press, Burlington, London2010
• The Spectrum of Renal Osteodystrophy and Vascular Calcifications in Uremia 
  Chapter: Phosphatonins in health and disease. 
  Page 379 - 403Thomas L, Sinha M, Kumar REditors: Olgaard K, Salusky IB, Silver J.Oxford University Press2010
• Osteoporosis. 
  Chapter: Phosphatonins. 
  Page 451 - 466Tebben PJ, Berndt TJ, Kumar REditors: Marcus R, et al..Elsevier Academic Press, Amsterdam, BostonEdition 3rd,2008
• Seldin and Giebisch's the kidney 
  Chapter: The hormonal regulation of calcium metabolism. 
  Page 1891 - 1909Tebben PJ, Kumar R2008
• The Kidney:Physiology and Pathophysiology 
  Chapter: Clinical disturbances of phosphate homeostasis. 
  Page 1989 - 2006Berndt TJ, Kumar REditors: Alpern RJ, Hebert SC.Elsevier Academic PressEdition 4th,2006
• Primer on the metabolic bone diseases and disorders of mineral metabolism 
  Chapter: Fanconi syndrome and renal tubular acidosis. 
  Tebben PJ, Thomas LF, Kumar REditors: Favus MJ.American Society for Bone and Mineral Research, Washington, DCEdition 6th,2006
• Vitamin D. Volume 1. 
  Chapter: Vitamin D and the kidney. 
  Page 515 - 536Tebben P, Kumar REditors: Feldman D.Elsevier Academic Press, AmsterdamEdition 2nd,2005
• Primer on the metabolic bone diseases and disorders of mineral metabolism. 
  Chapter: Fanconi syndrome and renal tubular acidosis. 
  Page 426 - 430Tebben PJ, Kumar REditors: Favus MJ.American Society for Bone and Mineral Research, Washington, DCEdition 5th,2003
• Osteomalacia 
  Chapter: Tumor-Induced Osteomalacia. 
  Kumar RSpringer-Verlag2003
• Endocrinologists. 
  Chapter: The Impact of Fuller Albright on My Research. 
  Kumar RLippincott Williams & Wilkins2002
• The Kidney: Physiology and Pathophysiology. 
  Chapter: Hormonal regulation of calcium metabolism. 
  Page 1791 - 1809Veenstra TD, Kumar REditors: Seldin DW, Giebisch G.Lippincott Williams & Wilkins, Philadelphia, PAEdition Thir,2000
• Atlas of Diseases of the Kidney. Volume One. 
  Chapter: Divalent cation metabolism: magnesium. 
  McCarthy JT, Kumar REditors: Berl T, Bonventre JV, Schrier RW.Current Medicine Inc., Philadelphia, PA1999
• Atlas of Diseases of the Kidney 
  Chapter: Divalent cation metabolism: calcium. 
  McCarthy JT, Kumar REditors: Berl T, Bonventre JV.Blackwell Science, Philadelphia, PA1999
• Renal Osteodystrophy 
  Chapter: Vitamin D. 
  Page 161 - 202Kumar REditors: Bushinsky DA.Lippincott-Raven Publishers, Philadelphia, PA1998
• Vitamin D 
  Chapter: Vitamin D and the kidney. 
  Page 275 - 292Kumar REditors: Feldman D.Academic Press, San Diego, CA1997
• Nephrology 
  Chapter: Vitamin D metabolism. 
  Page 205 - 214Kumar R , Craig TEditors: Jamison RL, Wilkinson R.Chapman & Hall, London1997
• Medicine for the Practicing Physician 
  Chapter: Osteomalacia. 
  Page 670 - 674Kumar REditors: Hurst JW.Appleton & Lange, StamfordEdition Four,1996
• Fluids and Electrolytes 
  Chapter: Calcium disorders. 
  Page 391 - 419Kumar REditors: Kokko JP, Tannen RL.W.B. Saunders Co.1996
• The Principles and Practice of Nephrology 
  Chapter: Calcium metabolism. 
  Page 964 - 971Kumar REditors: Jacobson HR, et al..Mosby, St. Louis1995
• Molecular Nephrology 
  Chapter: Vitamin D and the plasma membrane calcium pump. 
  Page 253 - 267Kumar R , Strehler EE, Cai QEditors: Schlondorff D, Bonventre JV.Marcel Dekker, Inc., New York1995
• The Principles and Practice of Nephrology. 
  Chapter: Renal osteodystrophy. 
  Page 1032 - 1045McCarthy JT, Kumar REditors: Jacobson HR, et al..Mosby, St. Louis1995
• Join now to see all

Abstracts/Posters

• Effects of paricalcitol on bone turnover in kidney transplant recipients.
  Amer H, Griffin M, Ryan Z, Park W, Kremers W, Stegall M, Cosio F, Kumar R, Transplantation, 7/15/2014
• Effects of paricalcitol on bone turnover in kidney transplant recipients.
  Amer H, Griffin M, Ryan Z, Park W, Kremers W, Stegall M, Cosio F, Kumar R, Am J Transplant, 6/1/2014
• Decreased renal clearance of uric acid is present in first time female kidney stone formers.
  Ketha H, Lieske JC, Bergstralh EJ, Li X, Kumar R , Rule AD, J Am Soc Nephrol., 1/1/2013
• The anti-phosphaturic effect of 1,25(OH)2D is impaired in nephrolithiasis.
  Ketha H, Singh R, Grebe S, Bergstralh EJ, Li X, Rule AD, Lieske JC, Kumar R, J Am Soc Nephrol., 1/1/2013
• Evidence for altered responsiveness of the vitamin D endocrine system to endogenous circulating parathyroid hormone in kidney stone formers.
  Ketha H, Singh R, Grebe S, Bergstralh EJ, Li X, Rule AD, Lieske JC, Kumar R, J Am Soc Nephrol, 1/1/2013
• Identification of bone-derived binding partners of human phosphate regulating endopeptidase mutated in x-linked hypophosphatemia (PHEX).
  Craig T, Kumar R, American Society for Bone and Mineral Research Annual Meeting, Minneapolis, MN, 10/12/2012
• Measurement of serum sclerostin by an enzyme-linked sandwich assay in sost wild type and knock-out mice.
  Dai X, Ryan ZC, Scribner Doering KB, Salerni BL, Wisherd C, Kumar R, American Society for Bone and Mineral Research Annual Meeting, Minneapolis, MN, 10/12/2012
• 1a,25-dihydroxyvitamin D3 regulates multiple novel metabolic pathways in developing zebrafish.
  Craig TA, Zhang Y, McNulty MS, Middha S, Magis AT, Funk C, Price ND, Ekker SC, Kumar R, American Society for Bone and Mineral Research Annual Meeting, Minneapolis, MN, 10/12/2012
• A liquid chromatography tandem mass spectrometric (LC-MS/MS) method for the quantification of 24,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D2 in human serum.
  Ketha H, Singh RJ, Kumar R, American Society for Bone and Mineral Research Annual Meeting, Minneapolis, MN, 10/12/2012
• Study of the transcriptional mechanism of DREAM by HDX/MS.
  Zhang J, Ramachandran P, Kumar R , Gross ML, American Society of Mass Spectrometry, Vancouver, Canada, 5/20/2012
• Oral paricalcitol in kidney transplant recipients receiving a corticosteroid-free immunosuppressive regimen: an open label randomized trial.
  Amer H, Griffin M, Cosio F, Park W, Kremers W, Mazur M, Hamawi K, Larson T, Stegall M, Kumar R, Am J Transplant, 5/1/2012
• Expression of sclerostin in the developing zebrafish brain and skeleton.
  McNulty MS, Bedell VM, Greenwood TM, Craig TA, Ekker SE, Kumar R, American Society for Bone and Mineral Research Annual Meeting, San Diego, CA, 9/16/2011
• Determination and comparison of serum and plasma sclerostin concentrations by commercially available enzyme-linked immunoassays.
  McNulty MS, Singh RJ, Li X, Bergstralh EJ, Kumar R, American Society for Bone and Mineral Research Annual Meeting, San Diego, CA, 9/16/2011
• A novel syndrome characterized by intermittent hypercalcemia, hypercalciuria, elevated serum calcitriol and undetectable 24, 25-dihydroxyvitamin D concentrations, neph...
  Tebben PJ, Milliner DS, Horst R, Kumar R, American Society for Bone and Mineral Research Annual Meeting, San Diego, CA, 9/16/2011
• Serum 25-hydroxyvitamin D is positively associated with enhanced pnuemococcal antibody titers in individuals with atopic conditions.
  Lee J, Zhao H, Fenta Y, Kita H, Kumar R , Juhn Y, J Allergy Clin Immunol, 2/1/2011
• Increased intestinal oxalate absorption, serum oxalate concentrations and urinary calcium oxalate supersaturation in patients after RYGB surgery.
  Kumar R , Lieske J, Collazo-Clavell M, Olson E, Li X, Bergstralh E, Ryan Z, American Society of Nephrology 41st Annual Renal Week Meeting, Denver, CO, 11/16/2010
• Effective management of hyperparathyroidism, vit D and Mineral metabolism following Roux-en-Y gastric bypass surgery.
  Kumar R , Lieske J, Olson E, Li X, Ryan Z, Bergstralh E, Collazo-Clavell M, American Society of Nephrology 41st Annual Renal Week Meeting, Denver, CO, 11/16/2010
• Improvements in glomerular hyperfiltration are associated with weight loss after Roux-en-Y bypass for obesity.
  Lieske J, Collazo-Clavell M, Olson E, Li X, Bergstralh E, Ryan Z, Kumar R, American Society of Nephrology 41st Annual Renal Week Meeting, Denver, CO, 11/16/2010
• Purification of intestinal phosphatonin from porcine intestine.
  Ryan Z, Kumar R, American Society of Nephrology 41st Annual Renal Week Meeting, Denver, CO, 11/16/2010
• Detection of sclerostin epitopes in zebrafish skeleton and kidney.
  Craig TA, Kumar R, American Society for Bone and Mineral Research 32nd Annual Meeting, Toronto, Canada, 10/15/2010
• Micro-computerized tomographic assessment of zebrafish skeleton.
  Craig TA, Kumar R, American Society for Bone and Mineral Research 32nd Annual Meeting, Toronto, Canada, 10/15/2010
• Mechanism of action of sclerostin: sclerostin interacts with the carboxyl terminal region of ErbB3.
  Craig TA, Kumar R, American Society for Bone and Mineral Research 32nd Annual Meeting, Toronto, Canada, 10/15/2010
• Dose dependent increases in renal phosphate excretion with administration of increasing concentrations of phosphate into the duodenum.
  Berndt T, Ryan Z, Li X, Bergstralh E, Kumar R, American Society of Nephrology 41st Annual Renal Week Meeting, San Diego, CA, 10/29/2009
• Intestine and liver contain a factor (an enteric phosphatonin) that inhibits sodium-dependent phosphate transport in opossum kidney (OK) cells.
  Ryan Z, Berndt T, Kumar R, American Society of Nephrology 41st Annual Renal Week Meeting, San Diego, CA, 10/29/2009
• Production and characterization of monoclonal antibodies to human sclerostin.
  Craig T, Kumar R, American Society for Bone and Mineral Research 31st Annual Meeting, Denver, CO, 9/11/2009
• Join now to see all

Lectures

• Fundamentals of Molecular Biology and Genetics 
  Scottsdale, AZ - 4/1/2001
• New Insights into Vitamin D Action. 
  Stanford, CA - 11/1/1998
• Phosphatonin - a new phosphaturetic hormone? (Lessons from tumor-induced osteomalacia and X-linked hypophosphatemia). 
  Iowa City, IA - 4/1/1997
• Polycystic kidney disease. 
  Iowa City, IA - 4/1/1997
• Pathogenesis and treatment of adult polycystic kidney disease. 
  Chicago, IL - 9/1/1996
• Calcium and phosphorus: Key physiologic principles 
  San Francisco, CA - 8/1/1996
• Vasopressin receptor endocytosis - physiological role. 
  Los Angeles, CA - 4/1/1996
• Adult polycystic kidney disease, Type 1: What's new and what is in the future. 
  Los Angeles, CA - 4/1/1996
• Inhibitors of renal phosphate transport in oncogenic osteomalacia and chronic renal failure. 
  Los Angeles, CA - 4/1/1996
• Mechanisms of calcium transport. 
  Los Angeles, CA - 4/1/1996
• Phosphatonin. 
  St. Louis, MO - 11/1/1995
• Regulation of phosphate transport and new insights into vitamin action. 
  St. Louis, MO - 11/1/1995
• Vitamin D receptor (VDR) regulation in the parathyroids of uremic patients. 
  Seville, Spain - 7/1/1995
• New concepts concerning the pathogenesis of hypophosphatemic bone disease. 
  Baltimore, MD - 4/1/1995
• Regulation of intestinal and renal calcium transport. 
  Dallas, TX - 4/1/1995
• The biology of phosphatonin -- a tumor-derived inhibitor of renal phosphate transport. 
  Tokyo, Japan - 12/1/1994
• The osteoblastic calcium pump. 
  Paris, France - 5/1/1994
• Advances in oncogenic osteomalacia. 
  Snowmass, CO - 3/1/1994
• Role of Vitamin D in tubular Ca2+ transport. 
  Jerusalem, Israel - 6/1/1993
• Vasopressin receptor internalization and desensitization. 
  Berlin, Germany - 5/1/1993
• Renal osteodystrophy and the vitamin D endocrine system. 
  Nashville, TN - 1/1/1993
• Vasopressin receptor endocytosis. 
  Nashville, TN - 1/1/1993
• Renal calcium ATPases. 
  Chicago, IL - 11/1/1991
• Vitamin D and mechanisms of calcium transport 
  Nashville, TN - 5/1/1991
• The physiology and cell biology of the vasopressin receptor. 
  Tulane University Medical Center, New Orleans, LA - 11/1/1990
• Join now to see all

Other

• DNA encoding HEM-1, a gene expressed by sclerosing hemangioma cells. 
  Kumar R, US Patent Number: US 5618695
  4/1/1997